Aclaris Therapeutics Correlations

ACRS Stock

USD 2.48 0.09 3.77%

The current 90-days correlation between Aclaris Therapeutics and Genetron Holdings is -0.03 (i.e., Good diversification). The correlation of Aclaris Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Aclaris Therapeutics Correlation With Market

Good diversification

The correlation between Aclaris Therapeutics and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

Moving together with Aclaris Stock

0.72	ESPR	Esperion Therapeutics	Pair Corr
0.73	LFCR	Lifecore Biomedical	Pair Corr

Moving against Aclaris Stock

0.75	PFE	Pfizer Inc Earnings Call This Week	Pair Corr
0.7	VALN	Valneva SE ADR Upward Rally	Pair Corr
0.5	ME	23Andme Holding	Pair Corr
0.4	PTN	Palatin Technologies	Pair Corr
0.35	GNFT	Genfit	Pair Corr
0.34	LLY	Eli Lilly Earnings Call This Week	Pair Corr
0.33	XWEL	XWELL Inc	Pair Corr
0.66	ALVO	Alvotech	Pair Corr
0.54	SHPH	Shuttle Pharmaceuticals	Pair Corr
0.46	PRPH	ProPhase Labs	Pair Corr
0.4	ABBV	AbbVie Inc Buyout Trend	Pair Corr
0.36	PTPI	Petros Pharmaceuticals	Pair Corr
0.31	ALTS	ALT5 Sigma Symbol Change	Pair Corr
0.53	CPHI	China Pharma Holdings	Pair Corr
0.45	TOVX	Theriva Biologics	Pair Corr
0.35	SMMT	Summit Therapeutics PLC	Pair Corr

Related Correlations Analysis

	NEOG	QGEN	OLK	SYNH	SHC	RDNT	MYGN	GTH	BDSX	CSTL
NEOG		-0.69	-0.89	-0.7	0.62	0.5	0.67	0.17	0.37	0.71	NEOG
QGEN	-0.69		0.66	0.49	-0.43	-0.4	-0.65	-0.2	-0.42	-0.52	QGEN
OLK	-0.89	0.66		0.73	-0.56	-0.58	-0.67	0.03	-0.51	-0.68	OLK
SYNH	-0.7	0.49	0.73		-0.88	-0.07	-0.77	-0.3	-0.46	-0.76	SYNH
SHC	0.62	-0.43	-0.56	-0.88		-0.13	0.7	0.42	0.36	0.68	SHC
RDNT	0.5	-0.4	-0.58	-0.07	-0.13		0.13	-0.32	0.28	0.35	RDNT
MYGN	0.67	-0.65	-0.67	-0.77	0.7	0.13		0.08	0.63	0.82	MYGN
GTH	0.17	-0.2	0.03	-0.3	0.42	-0.32	0.08		0.09	0.04	GTH
BDSX	0.37	-0.42	-0.51	-0.46	0.36	0.28	0.63	0.09		0.55	BDSX
CSTL	0.71	-0.52	-0.68	-0.76	0.68	0.35	0.82	0.04	0.55		CSTL
	NEOG	QGEN	OLK	SYNH	SHC	RDNT	MYGN	GTH	BDSX	CSTL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CSTL	+ 0.82	MYGN
SYNH	+ 0.73	OLK
CSTL	+ 0.71	NEOG
MYGN	+ 0.7	SHC
CSTL	+ 0.68	SHC
MYGN	+ 0.67	NEOG

High negative correlations

OLK	- 0.89	NEOG
SHC	- 0.88	SYNH
MYGN	- 0.77	SYNH
CSTL	- 0.76	SYNH
SYNH	- 0.7	NEOG
QGEN	- 0.69	NEOG

Risk-Adjusted Indicators

There is a big difference between Aclaris Stock performing well and Aclaris Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aclaris Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NEOG	2.20	(0.28)	0.00	(0.58)	0.00	0.00	3.92	(5.43)	11.56
QGEN	0.99	0.09	0.03	0.38	1.11	(1.17)	2.95	(1.95)	7.05
OLK	0.63	0.18	0.13	(1.08)	0.48	(0.76)	1.58	(1.37)	4.37
SYNH	0.67	0.08	0.03	0.35	0.85	(0.76)	2.13	(1.42)	9.20
SHC	1.59	(0.16)	0.00	1.53	0.00	0.00	3.30	(3.00)	10.53
RDNT	2.02	0.02	(0.02)	(0.27)	2.28	(2.41)	3.09	(3.69)	25.05
MYGN	2.26	(0.78)	0.00	(2.52)	0.00	0.00	3.09	(5.41)	20.32
GTH	1.87	0.04	(0.01)	(0.08)	2.49	(2.24)	3.45	(4.08)	14.43
BDSX	3.49	(0.56)	0.00	(26.75)	0.00	0.00	6.92	(8.87)	29.63
CSTL	2.51	(0.09)	0.00	0.62	0.00	0.00	4.85	(7.40)	23.12

Aclaris Therapeutics Corporate Executives

Elected by the shareholders, the Aclaris Therapeutics' board of directors comprises two types of representatives: Aclaris Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aclaris. The board's role is to monitor Aclaris Therapeutics' management team and ensure that shareholders' interests are well served. Aclaris Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aclaris Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Frank Ruffo

CFO CoFounder

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC